Get your free ETF data sample from our comprehensive offerings. Start your free trial

Help us improve your experience. Please confirm your investor type:

Compare ETFs Easily

The Ultimate ETF Comparison Tool - Try Now!

Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.

ETF IssuersiSharesEXV4
EXV4

iShares STOXX Europe 600 Health Care UCITS ETF (DE)

Passive ETFEquity

The EXV4 Exchange Traded Fund (ETF) is provided by iShares. It is built to track an index: STOXX Europe 600 Health Care Index. The EXV4 ETF provides physical exposure, so by buying it you actually own parts of all the 46 underlying holdings. This share class generates a stream of income by distributing dividends.

Advertisement

Advertisement

€113.22
-€1.5 (-1.34%) 1,165 days ago
4:02 PM 06/30/23 Open
1D price range
€113.22€115.24
52W price range
€100.06€123.22
YTD Perf.
+1.11%
YTD Flows
Annualized volatility
Fund AuM
€711M
Share class AuM
€711M
TTM Yield
Tracking Error
Tracking Difference
ISIN
DE000A0Q4R36
TER
0.46%
Inception date
4/25/2001
Issuer
Replication method
Dividend policy
Compare similar ETFs
API
PerformanceDec 30, 2025 - Sep 4, 2026
-5%0%5%10%JANMARMAYJULSEP
Flows
Join for free to unlock
Data as of 07/31/26
Healthcare
94.61%
Consumer Cyclicals
3.03%
Non-Energy Materials
1.18%
Unavailable
0.49%
Other
0.69%
Latest EXV4 news

FAQ about EXV4

EXV4 is a Passive ETF. This ETF provides exposure to European Health Care Equities.
EXV4 tracks the STOXX Europe 600 Health Care Net Return Index - EUR, through a full replication replication method.
EXV4 carries a total expense ratio (TER) of 0.46%, indicating the annual cost for holding the fund.
EXV4 was introduced to the market on April 25, 2001. It trades on Hungary, among other exchanges
iShares STOXX Europe 600 Health Care UCITS ETF (DE), EXV4, is provided by iShares. Learn more about iShares here.
EXV4 oversees €711M in assets as of September 4, 2026.
EXV4 follows a distributing dividend policy, meaning it pays out income to investors. As of September 4, 2026, its 12-month trailing yield was 1.64%.
As of July 31, 2026, EXV4 has significant geographic allocations in Switzerland, United Kingdom and Denmark.
As of July 31, 2026, EXV4 focuses largely on Healthcare, Consumer Cyclicals and Non-Energy Materials.
As of July 31, 2026, EXV4 holds 46 positions in its portfolio, with 83.99% of assets concentrated in its top 15 holdings.
As of July 31, 2026, EXV4 top three holdings include Roche Holding AG, Novartis AG and AstraZeneca PLC.
The base currency of EXV4 is EUR.
Data as of 07/31/26
Roche Holding AG
15.48%
Novartis AG
15.38%
AstraZeneca PLC
13.57%
Novo Nordisk A/S
8.42%
GSK Plc
5.43%
Sanofi
4.84%
EssilorLuxottica SA
3.03%
Bayer AG
2.82%
argenx SE
2.75%
Lonza Group AG
2.55%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight